Direkt zum Inhalt
Merck

Interleukin-13 drives metabolic conditioning of muscle to endurance exercise.

Science (New York, N.Y.) (2020-05-02)
Nelson H Knudsen, Kristopher J Stanya, Alexander L Hyde, Mayer M Chalom, Ryan K Alexander, Yae-Huei Liou, Kyle A Starost, Matthew R Gangl, David Jacobi, Sihao Liu, Danesh H Sopariwala, Diogo Fonseca-Pereira, Jun Li, Frank B Hu, Wendy S Garrett, Vihang A Narkar, Eric A Ortlund, Jonathan H Kim, Chad M Paton, Jamie A Cooper, Chih-Hao Lee
ZUSAMMENFASSUNG

Repeated bouts of exercise condition muscle mitochondria to meet increased energy demand-an adaptive response associated with improved metabolic fitness. We found that the type 2 cytokine interleukin-13 (IL-13) is induced in exercising muscle, where it orchestrates metabolic reprogramming that preserves glycogen in favor of fatty acid oxidation and mitochondrial respiration. Exercise training-mediated mitochondrial biogenesis, running endurance, and beneficial glycemic effects were lost in Il13-/- mice. By contrast, enhanced muscle IL-13 signaling was sufficient to increase running distance, glucose tolerance, and mitochondrial activity similar to the effects of exercise training. In muscle, IL-13 acts through both its receptor IL-13Rα1 and the transcription factor Stat3. The genetic ablation of either of these downstream effectors reduced running capacity in mice. Thus, coordinated immunological and physiological responses mediate exercise-elicited metabolic adaptations that maximize muscle fuel economy.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Glukose(GO)-Testkit, sufficient for 20 assays